Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin - Concepedia

Concepedia

Publication | Open Access

Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin

DOI Full Paper Access

689

Citations

20

References

2005

Year

Brian G. Feagan, Gordon R. Greenberg, Gary Wild, Richard N. Fedorak, Pierre Paré, John WD McDonald, Réjean Dubé, Albert Cohen, A. Hillary Steinhart, Steven B. Landau,

New England Journal of Medicine

Abstract

In this short-term study, MLN02 was more effective than placebo for the induction of clinical and endoscopic remission in patients with active ulcerative colitis.

References

	Year	Citations
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis Kenneth W. Schroeder, William J. Tremaine, Duane M. Ilstrup New England Journal of Medicine	1987	3K
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease Filip Baert, Maja Noman, Séverine Vermeire, New England Journal of Medicine	2003	2K
α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1 C Berlin, Ellen L. Berg, Michael Briskin, Cell Inflammationα4β7 Integrin MediatesMolecular ImmunologyMolecular PhysiologyCell Signaling	1993	1.4K
Replacing the complementarity-determining regions in a human antibody with those from a mouse Peter Jones, Paul H. Dear, Jefferson Foote, Nature Complement SystemImmunocytochemical TechniqueAutoimmune DiseaseHuman AntibodyImmunology	1986	1.4K
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis David H. Miller, Omar Khan, William Sheremata, New England Journal of Medicine	2003	1.2K
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study William A. Faubion, Edward V. Loftus, William S. Harmsen, Gastroenterology InflammationChronic Inflammatory DiseasesAnti-inflammatoryImmunologyNatural History	2001	1.1K
Natalizumab for Active Crohn's Disease Subrata Ghosh, Eran Goldin, F. Gordon, New England Journal of Medicine	2003	814
Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease E. Jan Irvine, Brian G. Feagan, James Rochon, Gastroenterology InflammationQuality Of LifeLife AssessmentFunctional Gastrointestinal DisorderGastroenterology	1994	715
Variation Between Observers in Describing Mucosal Appearances in Proctocolitis J H Baron, Alastair M. Connell, J E Lennard-Jones BMJ Traumatic Brain InjuryWhite MatterGastroenterologyPathologyBrain Lesion	1964	618
Microscopic activity in ulcerative colitis: what does it mean? S A Riley, V Mani, Michael J. Goodman, Gut InflammationHistopathologyGastroenterologyPathologySepsis	1991	572

Page 1